PRL and COVID-19: During the first visit, patients in the active phase of COVID-19 had noticeably elevated levels of prolactin in comparison to healthy patients (first visit: 422.60 ± 53.18 ng/mL vs. 283.48 ± 32.75 ng/mL) (Figure 4a).